Duration of Anticoagulant Effect in Relation to Urinary Excretion of Dextran Sulphate
- 3 November 1956
- Vol. 2 (5000), 1016-1023
- https://doi.org/10.1136/bmj.2.5000.1016
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dextran Sulphate: Use as an Anticoagulant, and Action in Lowering Serum CholesterolBMJ, 1956
- The Effect of Dextran Sulphate Injections on Serum LipoproteinsJournal of Clinical Pathology, 1956
- IN VIVO AND IN VITRO COMPARATIVE ASSAYS OF THE ANTICOAGULANT ACTIVITY OF DEXTRAN SULPHATE AND HEPARINBritish Journal of Pharmacology and Chemotherapy, 1955
- DEXTRAN SULPHATE: THE RELATION OF MOLECULAR FEATURES TO BIOLOGICAL PROPERTIESBritish Journal of Pharmacology and Chemotherapy, 1953
- THERAPEUTIC TRIAL OF THE SYNTHETIC HEPARIN ANALOGUE DEXTRAN SULPHATEThe Lancet, 1953
- OBSERVATIONS ON THE EFFECTS OF A SERIES OF DEXTRAN SULPHATES OF VARYING MOLECULAR WEIGHT ON THE FORMED ELEMENTS OF THE BLOOD IN VITROBritish Journal of Pharmacology and Chemotherapy, 1953
- The Metachromatic Activity of Urine Following the Injection of HeparinCirculation Research, 1953
- THE TURNOVER RATE OF SERUM ALBUMIN IN MAN AS MEASURED BY I131-TAGGED ALBUMIN 1JCI Insight, 1951
- Blood Lipids and Human AtherosclerosisCirculation, 1951
- The Use of Sulphated Whole Blood in the Assay of HeparinJournal of Pharmacy and Pharmacology, 1950